Arwan Pharmaceutical Industrials Lebanon s.a.l. was established with an aim to expand the horizon of Arab pharmaceutical manufacturers beyond the confines of traditional medicine, targeting critical care, life saving products including the biosimilars.
Accordingly, Arwan is well-equipped and prepared to host such an industry as per the international guidelines.
While the highest standards and measures are followed in the manufacturing processes to assure quality, after-sales tracking and follow-up are implemented to collect feedback pertaining to the efficacy and safety of our products, whether in initiating clinical studies (Phase IV, post marketing), through the well-trained local DSOs (Drug Safety Officers) and regional MLMs (Medical Liaison Managers), or via the on-line “Adverse Drug Reaction Reporting Form”.